{"2411.09820": {"publish_time": "2024-11-14", "title": "WelQrate: Defining the Gold Standard in Small Molecule Drug Discovery Benchmarking", "paper_summary": "While deep learning has revolutionized computer-aided drug discovery, the AI\ncommunity has predominantly focused on model innovation and placed less\nemphasis on establishing best benchmarking practices. We posit that without a\nsound model evaluation framework, the AI community's efforts cannot reach their\nfull potential, thereby slowing the progress and transfer of innovation into\nreal-world drug discovery. Thus, in this paper, we seek to establish a new gold\nstandard for small molecule drug discovery benchmarking, WelQrate.\nSpecifically, our contributions are threefold: WelQrate Dataset Collection - we\nintroduce a meticulously curated collection of 9 datasets spanning 5\ntherapeutic target classes. Our hierarchical curation pipelines, designed by\ndrug discovery experts, go beyond the primary high-throughput screen by\nleveraging additional confirmatory and counter screens along with rigorous\ndomain-driven preprocessing, such as Pan-Assay Interference Compounds (PAINS)\nfiltering, to ensure the high-quality data in the datasets; WelQrate Evaluation\nFramework - we propose a standardized model evaluation framework considering\nhigh-quality datasets, featurization, 3D conformation generation, evaluation\nmetrics, and data splits, which provides a reliable benchmarking for drug\ndiscovery experts conducting real-world virtual screening; Benchmarking - we\nevaluate model performance through various research questions using the\nWelQrate dataset collection, exploring the effects of different models, dataset\nquality, featurization methods, and data splitting strategies on the results.\nIn summary, we recommend adopting our proposed WelQrate as the gold standard in\nsmall molecule drug discovery benchmarking. The WelQrate dataset collection,\nalong with the curation codes, and experimental scripts are all publicly\navailable at WelQrate.org.", "paper_summary_zh": "<paragraph>\u6df1\u5ea6\u5b78\u7fd2\u96d6\u7136\u5fb9\u5e95\u6539\u8b8a\u4e86\u96fb\u8166\u8f14\u52a9\u85e5\u7269\u767c\u73fe\uff0c\u4f46 AI \u793e\u7fa4\u4e3b\u8981\u5c08\u6ce8\u65bc\u6a21\u578b\u5275\u65b0\uff0c\u8f03\u5c11\u91cd\u8996\u5efa\u7acb\u6700\u4f73\u57fa\u6e96\u6e2c\u8a66\u5be6\u52d9\u3002\u6211\u5011\u5047\u8a2d\uff0c\u82e5\u6c92\u6709\u5065\u5168\u7684\u6a21\u578b\u8a55\u4f30\u67b6\u69cb\uff0cAI \u793e\u7fa4\u7684\u52aa\u529b\u5c07\u7121\u6cd5\u767c\u63ee\u5176\u5168\u90e8\u6f5b\u529b\uff0c\u9032\u800c\u6e1b\u7de9\u5275\u65b0\u9032\u7a0b\uff0c\u4e26\u5c07\u5275\u65b0\u8f49\u79fb\u5230\u73fe\u5be6\u4e16\u754c\u7684\u85e5\u7269\u767c\u73fe\u4e2d\u3002\u56e0\u6b64\uff0c\u6211\u5011\u5728\u672c\u6587\u4e2d\u5c0b\u6c42\u70ba\u5c0f\u5206\u5b50\u85e5\u7269\u767c\u73fe\u57fa\u6e96\u6e2c\u8a66\u5efa\u7acb\u65b0\u7684\u91d1\u6a19\u6e96 WelQrate\u3002\u5177\u9ad4\u4f86\u8aaa\uff0c\u6211\u5011\u7684\u8ca2\u737b\u6709\u4e09\u65b9\u9762\uff1aWelQrate \u8cc7\u6599\u96c6\u6536\u96c6 - \u6211\u5011\u5f15\u9032\u4e00\u500b\u7cbe\u5fc3\u7b56\u5283\u7684 9 \u500b\u8cc7\u6599\u96c6\u96c6\u5408\uff0c\u6db5\u84cb 5 \u500b\u6cbb\u7642\u76ee\u6a19\u985e\u5225\u3002\u6211\u5011\u7684\u968e\u5c64\u5f0f\u7b56\u5283\u7ba1\u9053\u7531\u85e5\u7269\u767c\u73fe\u5c08\u5bb6\u8a2d\u8a08\uff0c\u900f\u904e\u5229\u7528\u5176\u4ed6\u78ba\u8a8d\u548c\u53cd\u5411\u7be9\u9078\u4ee5\u53ca\u56b4\u683c\u7684\u9818\u57df\u9a45\u52d5\u9810\u8655\u7406\uff08\u4f8b\u5982 Pan-Assay Interference Compounds (PAINS) \u904e\u6ffe\uff09\u8d85\u8d8a\u4e3b\u8981\u7684\u9ad8\u901a\u91cf\u7be9\u9078\uff0c\u4ee5\u78ba\u4fdd\u8cc7\u6599\u96c6\u4e2d\u7684\u8cc7\u6599\u54c1\u8cea\uff1bWelQrate \u8a55\u4f30\u67b6\u69cb - \u6211\u5011\u63d0\u51fa\u4e00\u500b\u6a19\u6e96\u5316\u7684\u6a21\u578b\u8a55\u4f30\u67b6\u69cb\uff0c\u8003\u91cf\u9ad8\u54c1\u8cea\u8cc7\u6599\u96c6\u3001\u7279\u5fb5\u5316\u30013D \u69cb\u8c61\u7522\u751f\u3001\u8a55\u4f30\u6307\u6a19\u548c\u8cc7\u6599\u5206\u5272\uff0c\u9019\u70ba\u9032\u884c\u771f\u5be6\u4e16\u754c\u865b\u64ec\u7be9\u9078\u7684\u85e5\u7269\u767c\u73fe\u5c08\u5bb6\u63d0\u4f9b\u53ef\u9760\u7684\u57fa\u6e96\u6e2c\u8a66\uff1b\u57fa\u6e96\u6e2c\u8a66 - \u6211\u5011\u900f\u904e\u4f7f\u7528 WelQrate \u8cc7\u6599\u96c6\u6536\u96c6\u4f86\u8a55\u4f30\u6a21\u578b\u6548\u80fd\uff0c\u63a2\u8a0e\u4e0d\u540c\u6a21\u578b\u3001\u8cc7\u6599\u96c6\u54c1\u8cea\u3001\u7279\u5fb5\u5316\u65b9\u6cd5\u548c\u8cc7\u6599\u5206\u5272\u7b56\u7565\u5c0d\u7d50\u679c\u7684\u5f71\u97ff\u3002\u7e3d\u4e4b\uff0c\u6211\u5011\u5efa\u8b70\u63a1\u7528\u6211\u5011\u63d0\u51fa\u7684 WelQrate \u4f5c\u70ba\u5c0f\u5206\u5b50\u85e5\u7269\u767c\u73fe\u57fa\u6e96\u6e2c\u8a66\u7684\u91d1\u6a19\u6e96\u3002WelQrate \u8cc7\u6599\u96c6\u6536\u96c6\uff0c\u9023\u540c\u7b56\u5283\u7a0b\u5f0f\u78bc\u548c\u5be6\u9a57\u8173\u672c\uff0c\u90fd\u516c\u958b\u65bc WelQrate.org\u3002</paragraph>", "author": "Yunchao et.al.", "authors": "Yunchao, Liu, Ha Dong, Xin Wang, Rocco Moretti, Yu Wang, Zhaoqian Su, Jiawei Gu, Bobby Bodenheimer, Charles David Weaver, Jens Meiler, Tyler Derr", "id": "2411.09820v1", "paper_url": "http://arxiv.org/abs/2411.09820v1", "repo": "null"}}